| ZEGA Stock | | | EUR 67.00 0.50 0.75% |
AstraZeneca PLC
fundamentals help investors to digest information that contributes to AstraZeneca PLC's financial success or failures. It also enables traders to predict the movement of AstraZeneca Stock. The
fundamental analysis module provides a way to measure
AstraZeneca PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various
microeconomic indicators and financial ratios related to AstraZeneca PLC stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to
Equity Screeners to view more equity screening tools.
AstraZeneca PLC Company Shares Owned By Insiders Analysis
AstraZeneca PLC's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Current AstraZeneca PLC Shares Owned By Insiders | | | | 0.04 % |
Most of AstraZeneca PLC's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AstraZeneca PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Based on the latest financial disclosure, 0.04% of AstraZeneca PLC are shares owned by insiders. This is 99.74% lower than that of the Healthcare sector and 98.46% lower than that of the
Drug Manufacturers - Major industry. The shares owned by insiders for all Germany stocks is 99.6% higher than that of the company.
| | Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
AstraZeneca Fundamentals
About AstraZeneca PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of AstraZeneca PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Currently Active Assets on Macroaxis
Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.